What We're Reading: Page 210
Industry reads hand-picked by our editors
Jan 23, 2020
-
Bloomberg
Deadly Viruses Aren't Pharma's Top Priority. Why Not?
-
POLITICO
White House prepared short list to shake up HHS leadership
-
The Irish Times
Takeda overhauls Shire’s Irish structure to ease dividend payments
-
BioCentury
FDA, CMS veteran Shah named FDA deputy commissioner for medical and scientific affairs
Jan 22, 2020
Jan 21, 2020
Jan 17, 2020
Jan 16, 2020
-
The Wall Street Journal
U.S. Targets Drug Pricing, No-Poach Deals for Antitrust Action in 2020
-
CNBC
Confusion and hype over 'digital health' overshadows J.P. Morgan health conference
-
Albany Business Review
Why Regeneron Pharmaceuticals bought a North Greenbush day care center
-
Endpoints News
Olivier Brandicourt follows the Big Pharma CEO path to private equity, joining Blackstone ahead of a mammoth fund debut
Jan 15, 2020
-
JAMA
Reform at the FDA
-
Bloomberg
Bankers Flooding JPMorgan Event Bemoan San Francisco Squalor
-
In the Pipeline
EQRx's Challenge, And My Challenge to Them
-
MIT Technology Review
A machine can now keep livers alive outside the body for a week
Jan 14, 2020
-
Science
FDA and NIH let clinical trial sponsors keep results secret and break the law
-
Reuters
Roche aims to 'underwhelm' on SMA drug price to challenge rivals
-
The Washington Post
What it’s like for one boy living with autism and Duchenne muscular dystrophy
-
FierceBiotech
Esperion tees up to launch cholesterol-busting meds—at affordable prices
Previous
